Everhart Financial Group Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.93M |
| 2 |
Microsoft
MSFT
|
+$1.64M |
| 3 |
NVIDIA
NVDA
|
+$1.61M |
| 4 |
Procter & Gamble
PG
|
+$1.08M |
| 5 |
Amazon
AMZN
|
+$998K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Morningstar Growth ETF
VUG
|
+$529K |
| 2 |
Goldman Sachs
GS
|
+$510K |
| 3 |
CVS Health
CVS
|
+$458K |
| 4 |
Vanguard Morningstar Value ETF
VTV
|
+$412K |
| 5 |
State Street SPDR S&P Dividend ETF
SDY
|
+$329K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 38.78% |
| 2 | Technology | 22.25% |
| 3 | Financials | 6.96% |
| 4 | Healthcare | 6.81% |
| 5 | Consumer Discretionary | 6.18% |
Similar funds
Everhart Financial Group's Q2 2024 Portfolio in Review
As of Q2 2024, Everhart Financial Group held 309 positions worth $385M, up 12% from $343M the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Everhart Financial Group deployed $28.8M of net new capital in Q2 2024, opening 32 new positions and adding to 201 existing holdings. Its largest new stake was Vaxcyte: 5,464 shares worth $413K.
By sector, the portfolio is most concentrated in Miscellaneous at 39% of assets, down from 42% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Vanguard Morningstar Growth ETF, an estimated $529K trimmed.
- Everhart Financial Group's largest Q2 2024 buy was Vaxcyte: 5,464 shares worth $413K.
- Everhart Financial Group added most to Apple in Q2 2024, an estimated $1.93M increase.
- Everhart Financial Group's biggest Q2 2024 reduction was Vanguard Morningstar Growth ETF, cutting an estimated $529K.
- Everhart Financial Group fully exited CVS Health in Q2 2024, selling an estimated $458K.
- Everhart Financial Group's ten largest holdings make up 37% of its $385M portfolio in Q2 2024.
- Everhart Financial Group opened 32 new positions and closed 16 in Q2 2024.
- Everhart Financial Group's portfolio value rose 12% quarter-over-quarter to $385M.
Based on Everhart Financial Group's 13F filing for Q2 2024, filed 24 Jul 2024.